137
Participants
Start Date
October 30, 2024
Primary Completion Date
March 30, 2028
Study Completion Date
April 30, 2030
valemetostat tosylate
Valemetostat will be administered orally once daily until RP2D of valemetostat is determined.
pembrolizumab
One IV infusion Q3W on D1 of each 21-day cycle for a maximum of 35 cycles.
RECRUITING
Hospital Italiano de Buenos Aires, Buenos Aires
RECRUITING
Instituto Alexander Fleming, Buenos Aires
NOT_YET_RECRUITING
Instituto Medico de La Fundacion Estudios Clinicos, Rosario
NOT_YET_RECRUITING
Fundacion Ars Medica, N Salvador de Jujuy
NOT_YET_RECRUITING
Columbia University Irving Medical Center, New York
RECRUITING
Montefiore Medical Center, The Bronx
NOT_YET_RECRUITING
The Catholic University of Korea, St. Vincent'S Hospital, Suwon
RECRUITING
Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
RECRUITING
Virginia Cancer Specialist, Fairfax
NOT_YET_RECRUITING
Mayo Clinic Hospital, Jacksonville
RECRUITING
University of Kentucky Medical Center, Lexington
RECRUITING
Pikeville Medical Center, Pikeville
NOT_YET_RECRUITING
Mayo Clinic - Rochester, Rochester
RECRUITING
California Research Institute, Los Angeles
RECRUITING
Valkyrie Clinical Trials, Los Angeles
RECRUITING
University of California San Diego (Ucsd)-Moores Cancer Center, La Jolla
NOT_YET_RECRUITING
The First Hospital of China Medical University, Shenyang
RECRUITING
Jilin Cancer Hospital, Changchun
NOT_YET_RECRUITING
The First Hospital of Jilin University, Changchun
RECRUITING
Harbin Medical University Cancer Hospital, Harbin
RECRUITING
Jiamusi Cancer Hospital, Jiamusi
RECRUITING
Shanghai East Hospital, Shanghai
RECRUITING
Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou
RECRUITING
Tianjin Medical University Cancer Institute & Hospital, Tiyuan
RECRUITING
Henan Cancer Hospital, Zhengzhou
NOT_YET_RECRUITING
Chengdu Shang Jin Nan Fu Hospital, Chengdu
RECRUITING
BRCR Global, Plantation
NOT_YET_RECRUITING
Sanatorio Allende, Córdoba
NOT_YET_RECRUITING
Centro de Investigacion Pergamino Sa, Pergamino
RECRUITING
Clinica Viedma S.A., Viedma
RECRUITING
Centro de Pesquisas Clinica Reichow, Blumenau
NOT_YET_RECRUITING
Clínica de Neoplasias Litoral Ltda., ItajaĂ-
RECRUITING
CINPAM Centro Integrado De Pesquisa Da Amazonia, Manaus
RECRUITING
Liga Norte-Rio-Grandense Contra o Câncer, Natal
RECRUITING
Hospital Nossa Senhora da Conceicao, Porto Alegre
NOT_YET_RECRUITING
Cepho - Centro de Estudos E Pesquisas de Hematologia E Oncologia, Santo André
RECRUITING
Fundacao Faculdade Regional de Medicina de Sao Jose Do Rio Preto, Sao Jose Rio Preto
RECRUITING
Kyushu University Hospital, Fukuoka
RECRUITING
National Cancer Center Hospital East, Kashiwa
RECRUITING
Cancer Institute Hospital of JFCR, Kōtoku
RECRUITING
NHO Nagoya Medical Center, Nagoya
RECRUITING
Kitasato University Hospital, Sagamihara-shi
NOT_YET_RECRUITING
Severance Hospital, Yonsei University Health System, Seoul
NOT_YET_RECRUITING
Samsung Medical Center, Seoul
NOT_YET_RECRUITING
Seoul National University Hospital, Seoul
Lead Sponsor
Merck Sharp & Dohme LLC
INDUSTRY
Daiichi Sankyo
INDUSTRY